James Sapirstein's Net Worth

$990 Thousand

Who is James Sapirstein?

James Sapirstein does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include RespireRx Pharmaceuticals Inc., Alliqua, Inc., Enochian Biosciences Inc, First Wave BioPharma, Inc., Probility Media Corp, Blue Water Biotech, Inc., ContraVir Pharmaceuticals, Inc., MARIZYME INC, Blue Water Acquisition Corp., and ZyVersa Therapeutics, Inc..

SEC CIK

James Sapirstein's CIK is 0001559509

Past Insider Trading and Trends

2017 was James Sapirstein's most active year for acquiring shares with 6 total transactions. James Sapirstein's most active month to acquire stocks was the month of February. 2023 was James Sapirstein's most active year for disposing of shares, totalling 3 transactions. James Sapirstein's most active month to dispose stocks was the month of September. 2021 saw James Sapirstein paying a total of $156,250.00 for 1,044,894 shares, this is the most they've acquired in one year. In 2013 James Sapirstein cashed out on 14,299 shares for a total of $63,773.54, their largest year based on trade value.